Pharmaceutical care in smoking cessation

11Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

As a determining factor in various diseases and the leading known cause of preventable mortality and morbidity, tobacco use is the number one public health problem in developed countries. Facing this health problem requires authorities and health professionals to promote, via specifc programs, health campaigns that improve patients’ access to smoking cessation services. Pharmaceutical care has a number of specifc characteristics that enable the pharmacist, as a health professional, to play an active role in dealing with smoking and deliver positive smoking cessation interventions. The objectives of the study were to assess the effcacy of a smoking cessation campaign carried out at a pharmaceutical care center and to evaluate the effects of pharmaceutical care on patients who decide to try to stop smoking. The methodology was an open, analytical, pre–post intervention, quasi-experimental clinical study performed with one patient cohort. The results of the study were that the promotional campaign for the smoking cessation program increased the number of patients from one to 22, and after 12 months into the study, 43.48% of the total number of patients achieved total smoking cessation. We can conclude that advertising of a smoking cessation program in a pharmacy increases the number of patients who use the pharmacy’s smoking cessation services, and pharmaceutical care is an effective means of achieving smoking cessation.

Cite

CITATION STYLE

APA

Armero, A. M. Í. N., Hernandez, M. A. C., Perez-Vicente, S., & Martinez-Martinez, F. (2015). Pharmaceutical care in smoking cessation. Patient Preference and Adherence, 9, 209–215. https://doi.org/10.2147/PPA.S67707

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free